SCHEMBL10635509

SCHEMBL10635509

CC(C)CCC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)CC=C(c5c(/C=C/C(=O)O)ccc(O)c5O)[C@@]45C[C@@]35CC[C@]12C

nearest known ligand 0.36

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 2/20 0.36
▸ ACACA Q13085 2/20 0.36
▸ EBP Q15125 8/20 0.36
▸ CDC25A P30304 2/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ HMGCR P04035 2/20 0.32
▸ PTPN11 Q06124 1/20 0.32
▸ PTGS1 P23219 1/20 0.30
▸ PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10634915 0.88 ACLY (0.35) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10634936 0.88 EBP (0.38) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10634885 0.87 ACLY (0.36) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10349851 0.87 ACLY (0.35) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10634974 0.86 ACLY (0.34) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10349522 0.84 ACLY (0.35) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10638570 0.82 EBP (0.40) ACLYACACAEBPHSD11B1CDC25B
Ferulate SCHEMBL2563897 0.80 MEN1 (0.42) ACLYACACAEBPHSD11B1PTGS1
SCHEMBL10638415 0.79 EBP (0.40) ACLYACACAEBPCDC25AHSD11B1
SCHEMBL10638617 0.78 EBP (0.41) ACLYACACAEBPHSD11B1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4748161-A Triterpenyl esters of organic acids and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1988-05-31 — — US disclosed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed
Send feedback